These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 6136457)

  • 21. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tardive dyskinesia induced by neuroleptics. A review of the literature].
    Diepart E; Cottereau MJ; Deniker P
    Encephale; 1979; 5(4):317-37. PubMed ID: 42528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromocriptine in tardive dyskinesia.
    Häggström JE; Andersson U; Gunne LM
    Pharmacopsychiatria; 1982 Sep; 15(5):161-3. PubMed ID: 6129649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    McGrath JJ; Soares KV
    Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
    Nair NP; Lal S; Schwartz G; Thavundayil JX
    Adv Biochem Psychopharmacol; 1980; 24():437-41. PubMed ID: 6773303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO
    Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gabaergic drugs on reserpine-induced oral dyskinesia.
    Peixoto MF; Araujo NP; Silva RH; Castro JP; Fukushiro DF; Faria RR; Zanier-Gomes PH; Medrano WA; Frussa-Filho R; Abílio VC
    Behav Brain Res; 2005 May; 160(1):51-9. PubMed ID: 15836900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In search of treatment for tardive dyskinesia: review of the literature.
    Jeste DV; Wyatt RJ
    Schizophr Bull; 1979; 5(2):251-93. PubMed ID: 37597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benzodiazepines and schizophrenia, a review of the literature].
    Gaillard R; Ouanas A; Spadone C; Llorca PM; Lôo H; Baylé FJ
    Encephale; 2006; 32(6 Pt 1):1003-10. PubMed ID: 17372546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of tardive dyskinesia: current update.
    Simpson GM; Pi EH; Sramek JJ
    Drugs; 1982 May; 23(5):381-93. PubMed ID: 7047137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug therapies for tardive dyskinesia: Part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Tardive' dyskinesia: etiological and therapeutic aspects.
    Awouters F; Niemegeers CJ; Janssen PA
    Pharmacopsychiatry; 1990 Jan; 23(1):33-7. PubMed ID: 2179973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of tardive dyskinesia.
    Egan MF; Apud J; Wyatt RJ
    Schizophr Bull; 1997; 23(4):583-609. PubMed ID: 9365997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical forms of severe tardive dyskinesia.
    Gardos G; Cole JO; Salomon M; Schniebolk S
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tardive dyskinesia--review of clinic, pathogenesis, prevention and treatment of a late neuroleptic side effect].
    Brücher K
    Fortschr Neurol Psychiatr; 1983 May; 51(5):183-99. PubMed ID: 6135655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.